|
⚲
|
| Keyboard |
| Bunnage Mark E
✚
|
|
|---|---|
| CIK # | 0002100735 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002100735] | |
| 4 | [0002100735] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Bunnage Mark E | |
| Vertex Pharmaceuticals Inc / Ma |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Vertex Pharmaceuticals Inc / Ma VRTX
Common Stock
|
2026-02-25 | Sell | 620 | $486.35 | 301,537 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Common Stock
|
2026-02-24 | Tax withheld | 582 | $485.11 | 282,334 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Common Stock
|
2026-02-18 | Sell | 1,182 | $473.68 | 559,890 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Common Stock
|
2026-02-17 | Sell | 2,437 | $489.46 | 1,192,814 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Common Stock
|
2026-02-17 | Tax withheld | 1,110 | $483.75 | 536,962 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Common Stock
|
2026-02-17 | Grant | 2,584 | $0.00 | |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Common Stock
|
2026-02-13 | Tax withheld | 2,283 | $487.76 | 1,113,556 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Common Stock
|
2026-02-11 | Sell | 2,021 | $460.43 | 930,529 |
|
Vertex Pharmaceuticals Inc / Ma VRTX
Common Stock
|
2026-02-10 | Tax withheld | 1,127 | $468.41 | 527,898 |